Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors (TEP-Sein)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors
Study Start Date
Primary Completion Date
Study Completion Date
Resource links provided by the National Library of Medicine
Performance of FDG-PET for the evaluation of nodal status [ Time Frame: 3 years ]
Show that the algorithm of high-definition positron emission tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) is greater than a classical algorithm in the diagnosis of lymph node metastases.
Secondary Outcome Measures
Information on lymph node status in patients with breast cancer. [ Time Frame: 3 years ]
Show that scintigraphy performed on a FDG positron camera equipped with a reconstruction algorithm for high-definition can provide reliable information on lymph node status in patients with breast cancer and determine the minimum size of lymph node metastatic lesions.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Preoperative assessment of breast cancer.
Informed consent and signed by the patient
Age ≥ 18 years
Breast tumor for which the therapeutic indication for surgery has from the outset: breast surgery (conservative or radical) associated with a conventional axillary dissection
Proof of infiltrating ductal carcinoma histology
No known metastasis
No cons-indication to anesthesia.
History of neoadjuvant therapy
Patients with invasive lobular carcinoma
Indication of the use of sentinel node (if invasive carcinoma uni-centric, ≤ 2 cm in diameter, without palpable lymphadenopathy (N0))
Diabetes is not controlled by conventional treatment (blood glucose> 1.8 g / l)
Inability to capital
Patients who are pregnant or nursing or of childbearing potential and not using adequate contraception
Persons deprived of their liberty
Major subject of a measure of legal protection or unable to consent